Cargando…

Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease

BACKGROUND: Patients with chronic kidney disease (CKD) are at an increased risk of developing end-stage renal disease (ESRD). We assessed for the first time whether urinary free light chains (FLC) are independently associated with risk of ESRD in patients with CKD, and whether they offer incremental...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fenton, Anthony, Jesky, Mark D., Webster, Rachel, Stringer, Stephanie J., Yadav, Punit, Chapple, Iain, Dasgupta, Indranil, Harding, Stephen J., Ferro, Charles J., Cockwell, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942781/ https://www.ncbi.nlm.nih.gov/pubmed/29742142 http://dx.doi.org/10.1371/journal.pone.0197043

Ejemplares similares

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
por: Jesky, Mark D., et al.
Publicado: (2016)

Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study
por: Ng, Khai P., et al.
Publicado: (2014)

The natural history of, and risk factors for, progressive Chronic Kidney Disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol
por: Stringer, Stephanie, et al.
Publicado: (2013)

Urinary endotrophin predicts disease progression in patients with chronic kidney disease
por: Rasmussen, Daniel Guldager Kring, et al.
Publicado: (2017)

Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease
por: Fenton, Anthony, et al.
Publicado: (2017)

Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients
por: Genovese, Federica, et al.
Publicado: (2020)

A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease
por: Holm Nielsen, Signe, et al.
Publicado: (2018)

Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study
por: Yadav, Punit, et al.
Publicado: (2020)

Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study
por: Fenton, Anthony, et al.
Publicado: (2020)

Association between periodontitis and mortality in stages 3–5 chronic kidney disease: NHANES III and linked mortality study
por: Sharma, Praveen, et al.
Publicado: (2016)

Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
por: Yadav, Punit, et al.
Publicado: (2018)

INfluence of Successful Periodontal Intervention in REnal Disease (INSPIRED): study protocol for a randomised controlled pilot clinical trial
por: Sharma, Praveen, et al.
Publicado: (2017)

The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study
por: Jesky, Mark, et al.
Publicado: (2013)

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
por: Hutchison, Colin A, et al.
Publicado: (2008)

Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU
por: Brothwell, Shona, et al.
Publicado: (2013)

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
por: Hutchison, Colin A, et al.
Publicado: (2012)

The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease
por: Assi, Lakhvir K., et al.
Publicado: (2015)

Correction: The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease
por: Assi, Lakhvir K., et al.
Publicado: (2015)

Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)
por: Ramirez-Alvarado, Marina, et al.
Publicado: (2012)

Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus
por: Jiang, Jun, et al.
Publicado: (2022)

Acute kidney injury is more common in men than women after accounting for socioeconomic status, ethnicity, alcohol intake and smoking history
por: Loutradis, Charalampos, et al.
Publicado: (2021)

Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test
por: Heaney, Jennifer L. J., et al.
Publicado: (2017)

Oxidative stress links periodontal inflammation and renal function
por: Sharma, Praveen, et al.
Publicado: (2021)

European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial
por: Hutchison, Colin A, et al.
Publicado: (2008)

Immunoglobulin Free Light Chain Dimers in Human Diseases
por: Kaplan, Batia, et al.
Publicado: (2011)

Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease
por: Arnold, Julia J, et al.
Publicado: (2015)

Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report
por: Basnayake, Kolitha, et al.
Publicado: (2008)

LIGHT CHAIN DEPOSITION DISEASE
por: Vos, Josephine M.I.
Publicado: (2022)

Pathologic light chain amyloidosis oligomer detection in urinary extracellular vesicles as a diagnostic tool for response and progression of disease
por: Cooper, Shawna A., et al.
Publicado: (2022)

Structural analysis of urinary light chains and proteomic analysis of hyaline tubular casts in light chain associated kidney disorders
por: Reiter, Thomas, et al.
Publicado: (2019)

Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease
por: Wall, Nadezhda A., et al.
Publicado: (2018)

Polyclonal light chains in cerebrovascular disease
por: Fiori, Patrizia, et al.
Publicado: (2010)

Immunoglobulin free light chains in adult atopic dermatitis patients do not correlate with disease severity
por: Thijs, J. L., et al.
Publicado: (2016)

Free Light Chains κ and λ as New Biomarkers of Selected Diseases
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023)

Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease
por: Sternke-Hoffmann, Rebecca, et al.
Publicado: (2020)

COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel?
por: Bloem, Bastiaan R., et al.
Publicado: (2021)

Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease
por: Nasr, Samih H., et al.
Publicado: (2021)

Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains
por: Wilhite, Dorian, et al.
Publicado: (2021)

Comment on “Clinical Comparisons of Two Free Light Chain Assays to Immunofixation Electrophoresis for Detecting Monoclonal Gammopathy”
por: Parker, Antony R., et al.
Publicado: (2015)

A case of light chain deposition disease involving the kidney with a normal serum free kappa/lambda light chain ratio
por: Zhang, Suojian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e98e2f5nebnjcd3nkibo95hnpq